Oxford Biomedica plc (OTCMKTS:OXBDF – Get Free Report) traded down 3.3% during mid-day trading on Thursday . The stock traded as low as $4.95 and last traded at $4.95. 200 shares were traded during mid-day trading, an increase of 84% from the average session volume of 109 shares. The stock had previously closed at $5.12.
Oxford Biomedica Stock Performance
The company’s 50 day simple moving average is $5.27 and its 200-day simple moving average is $4.86. The company has a quick ratio of 2.07, a current ratio of 2.35 and a debt-to-equity ratio of 1.48.
About Oxford Biomedica
Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.
See Also
- Five stocks we like better than Oxford Biomedica
- Why is the Ex-Dividend Date Significant to Investors?
- Cerence AI: One-Hit Wonder or Long-Term Winner After NVIDIA Pact?
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- UnitedHealth Group Pulls Back Into Another Healthy Opportunity
- CD Calculator: Certificate of Deposit Calculator
- Micron Technology: Riding the AI Wave to Long-Term Growth
Receive News & Ratings for Oxford Biomedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Biomedica and related companies with MarketBeat.com's FREE daily email newsletter.
